Biosynergy Inc (BSYN) financial statements (2022 and earlier)

Company profile

Business Address 55 WEST MONROE STREET
CHICAGO, IL 60603
State of Incorp. IL
Fiscal Year End April 30
SIC 3829 - Measuring and Controlling Devices, Not Elsewhere Classified (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

1/31/2022
TTM
4/30/2021
4/30/2019
4/30/2017
4/30/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,4851,2511,1801,0411,092
Cash and cash equivalents2,4851,2511,1801,0411,092
Receivables312265246268192
Inventory, net of allowances, customer advances and progress billings 145163186109
Inventory 145163186109
Prepaid expense2234   
Other undisclosed current assets150 583226
Total current assets:2,9681,6951,6471,5271,419
Noncurrent Assets
Operating lease, right-of-use asset1697
Property, plant and equipment 3122015
Long-term investments and receivables  202020
Due from related parties  202020
Intangible assets, net (including goodwill) 911197079
Intangible assets, net (excluding goodwill) 911197079
Other undisclosed noncurrent assets66755647
Total noncurrent assets:22197226166161
TOTAL ASSETS:2,9901,8921,8731,6921,580
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities39918262930
Accounts payable793545
Accrued liabilities3201044
Employee-related liabilities 14222222
Other undisclosed current liabilities2,5901101304239
Total current liabilities:2,9901281567269
Noncurrent Liabilities
Liabilities, other than long-term debt 25   
Deferred income tax liabilities 25
Total noncurrent liabilities: 25   
Total liabilities:2,9901531567269
Stockholders' equity
Stockholders' equity attributable to parent, including: 1,7391,6921,5861,478
Common stock 661   
Retained earnings 1,1031,051944837
Other undisclosed stockholders' equity attributable to parent (25)641641641
Total stockholders' equity: 1,7391,6921,5861,478
Other undisclosed liabilities and equity  243532
TOTAL LIABILITIES AND EQUITY:2,9901,8921,8731,6921,580

Income statement (P&L) ($ in thousands)

1/31/2022
TTM
4/30/2021
4/30/2019
4/30/2017
4/30/2016
Revenues2,1851,17321,2931,338
Revenue, net1,2931,338
Other income  2  
Cost of revenue(618)(434)(423)(376)(415)
Cost of goods and services sold  (423)(376)(415)
Other undisclosed gross profit(859) 1,289  
Gross profit:708739869916923
Operating expenses(1,000)(722)(769)(768)(778)
Operating income (loss):(291)17100149145
Nonoperating income1,24112   
Other nonoperating income211   
Other undisclosed income from continuing operations before equity method investments, income taxes12    
Income from continuing operations before income taxes:96129100149145
Income tax expense(251)(14)(29)(44)(41)
Net income:7111671105104
Other undisclosed net income (loss) attributable to parent(11) 222
Net income available to common stockholders, diluted:6991673107106

Comprehensive Income ($ in thousands)

1/31/2022
TTM
4/30/2021
4/30/2019
4/30/2017
4/30/2016
Net income:7111671105104
Comprehensive income, net of tax, attributable to parent:7111671105104

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: